跳至主要内容
临床试验/NCT02847975
NCT02847975已完成1 期

Sodium Nitrate to Improve Blood Flow

Cedars-Sinai Medical Center4 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2013年10月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
11
试验地点
4
主要终点
change in muscle tissue oxygenation

研究概览

简要总结

Investigators recently showed that tadalafil restores functional sympatholysis in patients with Becker muscular dystrophy (BMD). If tadalafil restores functional sympatholysis in BMD via the NO-cyclic guanosine monophosphate pathway, then functional sympatholysis should also be restored by sodium nitrite- which is an indirect nitric oxide donor.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
15 Years 至 55 Years(Child, Adult)
性别
Male
接受健康志愿者

入选标准

  • Becker muscular dystrophy
  • age 15-55 years of age
  • ambulatory

排除标准

  • hypertension, diabetes, or heart failure by standard clinical criteria
  • elevated brain natriuretic peptide level (>100 pg/ml)
  • Left ventricular ejection fraction < 50%
  • cardiac rhythm disorder, specifically: rhythm other than sinus, supraventricular tachycardia, atrial fibrillation, ventricular tachycardia, heart block
  • continuous ventilatory support
  • liver disease
  • renal impairment
  • history of asthma or bronchospasm
  • use of any medications other than common supplements
  • unable to perform handgrip exercise

研究组 & 干预措施

Sodium nitrate

Experimental

Sodium nitrate will be administered orally and functional sympatholysis assessed before and after treatment

干预措施: Sodium nitrate (Dietary Supplement)

结局指标

主要结局

change in muscle tissue oxygenation

时间窗: change from baseline to post treatment (3-4 hours)

The pre-specified primary outcome is the pre vs. post treatment change in functional sympatholysis measured by muscle oxygenation.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ron Victor

Professor of Medicine

Cedars-Sinai Medical Center

研究点 (4)

Loading locations...

相似试验

Sodium Nitrate to Improve Blood Flow | 临床试验